Exelixis (US.EXEL)
Capital Allocation Audit · Period: 2010 – 2026
Key Metrics
US.EXEL · YoY: 2026 Q1 vs 2025 Q1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 99.2% | ↑ |
| ROE | 10.9% | ↑ |
| Cash Conversion | 119.7% | ↓ |
| D/E Ratio | 0.09 | → |
| Gross Margin | 96.7% | → |
US.EXEL (Exelixis) | YoY: 2026 Q1 vs 2025 Q1 Metric Value YoY ---------------------------- FCF Conversion 99.2% ↑ ROE 10.9% ↑ Cash Conversion 119.7% ↓ D/E Ratio 0.09 → Gross Margin 96.7% →
Key Metrics
US.EXEL (Exelixis) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY----------------------------FCF Conversion 99.2% ↑ROE 10.9% ↑Cash Conversion 119.7% ↓D/E Ratio 0.09 →Gross Margin 96.7% →Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies